We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
- Authors
Rosenheck, Robert; Perlick, Deborah; Bingham, Stephen; Liu-Mares, Wen; Collins, Joseph; Warren, Stuart; Leslie, Douglas; Allan, Edward; Campbell, E Cabrina; Caroff, Stanley; Corwin, June; Davis, Lori; Douyon, Richard; Dunn, Lawrence; Evans, Denise; Frecska, Ede; Grabowski, John; Graeber, David; Herz, Lawrence; Kwon, Kong; Lawson, William; Mena, Felicitas; Sheikh, Javaid; Smelson, David; Smith-Gamble, Valerie; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine
- Abstract
Although olanzapine has been widely adopted as a treatment of choice for schizophrenia, its long-term effectiveness and costs have not been evaluated in a controlled trial in comparison with a standard antipsychotic drug.
- Publication
JAMA, 2003, Vol 290, Issue 20, p2693
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.290.20.2693